Sam-A Pharm (Korea) Market Value
| 009300 Stock | KRW 16,600 1,010 6.48% |
| Symbol | Sam-A |
Sam-A Pharm 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sam-A Pharm's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sam-A Pharm.
| 08/19/2023 |
| 12/11/2024 |
If you would invest 0.00 in Sam-A Pharm on August 19, 2023 and sell it all today you would earn a total of 0.00 from holding Sam A Pharm Co or generate 0.0% return on investment in Sam-A Pharm over 480 days. Sam-A Pharm is related to or competes with Kolon Life, JETEMA Co, Aminologics CoLtd, Daihan Pharmaceutical, HLB Pharmaceutical, Withuspharmaceutical, and Choong Ang. Co., Ltd operates as a pharmaceutical company in South Korea More
Sam-A Pharm Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sam-A Pharm's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sam A Pharm Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 7.9 | |||
| Value At Risk | (3.88) | |||
| Potential Upside | 2.8 |
Sam-A Pharm Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sam-A Pharm's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sam-A Pharm's standard deviation. In reality, there are many statistical measures that can use Sam-A Pharm historical prices to predict the future Sam-A Pharm's volatility.| Risk Adjusted Performance | (0.15) | |||
| Jensen Alpha | (0.50) | |||
| Total Risk Alpha | (0.81) | |||
| Treynor Ratio | (1.81) |
Sam A Pharm Backtested Returns
Sam A Pharm owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.22, which indicates the firm had a -0.22% return per unit of risk over the last 3 months. Sam A Pharm Co exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sam-A Pharm's Risk Adjusted Performance of (0.15), coefficient of variation of (462.14), and Variance of 4.53 to confirm the risk estimate we provide. The entity has a beta of 0.26, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Sam-A Pharm's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sam-A Pharm is expected to be smaller as well. At this point, Sam A Pharm has a negative expected return of -0.46%. Please make sure to validate Sam-A Pharm's coefficient of variation, jensen alpha, treynor ratio, as well as the relationship between the standard deviation and total risk alpha , to decide if Sam A Pharm performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.17 |
Insignificant reverse predictability
Sam A Pharm Co has insignificant reverse predictability. Overlapping area represents the amount of predictability between Sam-A Pharm time series from 19th of August 2023 to 15th of April 2024 and 15th of April 2024 to 11th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sam A Pharm price movement. The serial correlation of -0.17 indicates that over 17.0% of current Sam-A Pharm price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.17 | |
| Spearman Rank Test | 0.13 | |
| Residual Average | 0.0 | |
| Price Variance | 23.8 M |
Sam A Pharm lagged returns against current returns
Autocorrelation, which is Sam-A Pharm stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sam-A Pharm's stock expected returns. We can calculate the autocorrelation of Sam-A Pharm returns to help us make a trade decision. For example, suppose you find that Sam-A Pharm has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sam-A Pharm regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sam-A Pharm stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sam-A Pharm stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sam-A Pharm stock over time.
Current vs Lagged Prices |
| Timeline |
Sam-A Pharm Lagged Returns
When evaluating Sam-A Pharm's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sam-A Pharm stock have on its future price. Sam-A Pharm autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sam-A Pharm autocorrelation shows the relationship between Sam-A Pharm stock current value and its past values and can show if there is a momentum factor associated with investing in Sam A Pharm Co.
Regressed Prices |
| Timeline |
Pair Trading with Sam-A Pharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sam-A Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sam-A Pharm will appreciate offsetting losses from the drop in the long position's value.Moving together with Sam-A Stock
Moving against Sam-A Stock
| 0.67 | 030200 | KT Corporation | PairCorr |
| 0.55 | 011200 | HMM Co | PairCorr |
| 0.47 | 065660 | AnterogenCoLtd | PairCorr |
| 0.36 | 023910 | Daihan Pharmaceutical | PairCorr |
The ability to find closely correlated positions to Sam-A Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sam-A Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sam-A Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sam A Pharm Co to buy it.
The correlation of Sam-A Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sam-A Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sam A Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sam-A Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Sam-A Stock
Sam-A Pharm financial ratios help investors to determine whether Sam-A Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam-A with respect to the benefits of owning Sam-A Pharm security.